Search research articles
Contact Us
Filters
Showing results (101-110 of 121) with videos related to
Page
of 13
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 6, 2024
Receptor-Targeted Peptide Conjugates Based on Diphosphines Enable Preparation of <sup>99m</sup>Tc and <sup>188</sup>Re Theranostic Agents for Prostate Cancer
Truc T Pham, Ingebjørg N Hungnes, Charlotte Rivas, et al.
European Radiology
|
February 22, 2024
Predicting programmed death-ligand 1 (PD-L1) expression with fluorine-18 fluorodeoxyglucose ([<sup>18</sup>F]FDG) positron emission tomography/computed tomography (PET/CT) metabolic parameters in resectable non-small cell lung cancer
Daniel Johnathan Hughes, Eleni Josephides, Robert O'Shea, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 20, 2021
A Phase II, Open-label study to assess safety and management change using <sup>68</sup>Ga-THP PSMA PET/CT in patients with high risk primary prostate cancer or biochemical recurrence after radical treatment: The PRONOUNCED study
Asim Afaq, Heather Payne, Reena Davda, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 19, 2026
Does <sup>18</sup>F-sodium fluoride PET/CT have a role in the assessment of response to <sup>223</sup>Ra therapy in men with prostatic bone metastases?
Glen M Blake, Ricardo Donners, Amelia E B Moore, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
December 11, 2025
An explainable imaging-clinical biomarker for non-small cell lung cancer prognostication based on normalised hotspot to centroid distance and [<sup>18</sup>F]FDG PET/CT radiomics
Mitchell Chen, Susan J Copley, Yidong Han, et al.
Chemical Science
|
September 17, 2025
Maleic anhydride derived diphosphines: adaptable chelators for receptor-targeted <sup>99m</sup>Tc, <sup>64</sup>Cu and <sup>188</sup>Re radiotracers
Rachel E Nuttall, Ingebjørg N Hungnes, Truc T Pham, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 1, 2024
Joint EANM-SNMMI guidelines on the role of 2-[<sup>18</sup>F]FDG PET/CT in no special type breast cancer: differences and agreements with European and American guidelines
David Groheux, Sofia C Vaz, Gary A Ulaner, et al.
Frontiers in Endocrinology
|
October 2, 2023
Utility of a simplified [<sup>18</sup>F] sodium fluoride PET imaging method to quantify bone metabolic flux for a wide range of clinical applications
Tanuj Puri, Michelle L Frost, Amelia E B Moore, et al.
Breast (Edinburgh, Scotland)
|
September 20, 2024
Role of [<sup>18</sup>F]FDG PET/CT in patients with invasive breast carcinoma of no special type: Literature review and comparison between guidelines
David Groheux, Sofia C Vaz, Philip Poortmans, et al.
JNCI Cancer Spectrum
|
October 3, 2023
Radium-223 in metastatic castration-resistant prostate cancer: whole-body diffusion-weighted magnetic resonance imaging scanning to assess response
Chris Parker, Nina Tunariu, Holly Tovey, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 121) with videos related to
Sort By:
Page
of 13
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 6, 2024
Receptor-Targeted Peptide Conjugates Based on Diphosphines Enable Preparation of <sup>99m</sup>Tc and <sup>188</sup>Re Theranostic Agents for Prostate Cancer
Truc T Pham, Ingebjørg N Hungnes, Charlotte Rivas, et al.
European Radiology
|
February 22, 2024
Predicting programmed death-ligand 1 (PD-L1) expression with fluorine-18 fluorodeoxyglucose ([<sup>18</sup>F]FDG) positron emission tomography/computed tomography (PET/CT) metabolic parameters in resectable non-small cell lung cancer
Daniel Johnathan Hughes, Eleni Josephides, Robert O'Shea, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 20, 2021
A Phase II, Open-label study to assess safety and management change using <sup>68</sup>Ga-THP PSMA PET/CT in patients with high risk primary prostate cancer or biochemical recurrence after radical treatment: The PRONOUNCED study
Asim Afaq, Heather Payne, Reena Davda, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 19, 2026
Does <sup>18</sup>F-sodium fluoride PET/CT have a role in the assessment of response to <sup>223</sup>Ra therapy in men with prostatic bone metastases?
Glen M Blake, Ricardo Donners, Amelia E B Moore, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
December 11, 2025
An explainable imaging-clinical biomarker for non-small cell lung cancer prognostication based on normalised hotspot to centroid distance and [<sup>18</sup>F]FDG PET/CT radiomics
Mitchell Chen, Susan J Copley, Yidong Han, et al.
Chemical Science
|
September 17, 2025
Maleic anhydride derived diphosphines: adaptable chelators for receptor-targeted <sup>99m</sup>Tc, <sup>64</sup>Cu and <sup>188</sup>Re radiotracers
Rachel E Nuttall, Ingebjørg N Hungnes, Truc T Pham, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 1, 2024
Joint EANM-SNMMI guidelines on the role of 2-[<sup>18</sup>F]FDG PET/CT in no special type breast cancer: differences and agreements with European and American guidelines
David Groheux, Sofia C Vaz, Gary A Ulaner, et al.
Frontiers in Endocrinology
|
October 2, 2023
Utility of a simplified [<sup>18</sup>F] sodium fluoride PET imaging method to quantify bone metabolic flux for a wide range of clinical applications
Tanuj Puri, Michelle L Frost, Amelia E B Moore, et al.
Breast (Edinburgh, Scotland)
|
September 20, 2024
Role of [<sup>18</sup>F]FDG PET/CT in patients with invasive breast carcinoma of no special type: Literature review and comparison between guidelines
David Groheux, Sofia C Vaz, Philip Poortmans, et al.
JNCI Cancer Spectrum
|
October 3, 2023
Radium-223 in metastatic castration-resistant prostate cancer: whole-body diffusion-weighted magnetic resonance imaging scanning to assess response
Chris Parker, Nina Tunariu, Holly Tovey, et al.
Page
of 13